Cough and Cold Medications Experiencing 535% Growth as a Result of Coronavirus - ResearchAndMarkets.com

DUBLIN--()--ResearchAndMarkets.com published new article on the pharmaceutical industry, "Cough and Cold Medications Experiencing 535% Growth as a Result of Coronavirus."

In response to the COVID-19 pandemic, many consumers have started stocking up on over-the-counter cold and flu medications, cough suppressants, lozenges and painkillers in order to be prepared in case they begin to experience symptoms of the virus. Many pharmaceutical companies are seeing increased demand for their over-the-counter products as a result, including:

  • GlaxoSmithKline
  • Vernalis
  • Pfizer
  • Taro Pharmaceuticals
  • Bayer

ResearchAndMarkets.com offer a wide range of reports on that cover the above topics & companies, across all geographic markets.

To see the full article and a list of related reports on the market, visit: "ResearchAndMarkets.com: Cough and Cold Medications Experiencing 535% Growth as a Result of Coronavirus"

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900